Medipattern, a company that specialises in healthcare prevention and analysis solutions, has set up a new business unit following the acquisition, including intellectual property and patents, of Mytrak Health System’s mobile technology unit.  

The company will combine its imaging and pattern-recognition algorithms with Mytrak’s wearable lifestyle technology and what it describes as behaviour modification system into a new unit which is called Medipattern mHealth Solutions. The company announced the creation of the new unit alongside the closing of the Mytrak acquisition.

The aim of the unit is to enable users to better manage disease with a particular focus on metabolic syndrome, cardiovascular disease, obesity and diabetes. Mixing Medipattern and Mytrak’s technology the new unit will search for patterns in users’ everyday data. These could include aberrations in heart, health and energy that could be an early warning of oncoming disease. 

Under the terms of the transaction, Medipattern issued 11.4 million common shares to Mytrak and paid US$500,000 in cash on closing the deal with an additional US$500,000 due to be paid to Mytrak on the achievement of a future milestone.